Kaipharm Co.
Latest round
- Series A
Last raised
- Jan 2020
Total raised
- $4.3M
Investors
- 7
About Kaipharm Co.
Based in Seoul, South Korea, and founded in 2018 by CEO Wankyu Kim, Kaipharm Co.a. Kaipharm is an AI (artificial intelligence)-driven drug discovery company that builds a database of compound structures, drug-disease relationships, drug-target relationships, drug-induced transcriptome, and data mining technologies for developing artificial intelligence (AI) algorithms and providing complex solutions. In February 2020, Kaipharm Co. Ltd. The company provides a drug-induced transcriptome platform that offers information on drug mode-of-action (MoA), reflecting genome-wide perturbation on gene expression by drug treatment for targets and unknown off-targets. Kaipharm also offers KMAP, an integrated platform for analyzing drug-induced transcriptome data that enables MoA analysis and identification of novel indications for a given drug. In addition, the firm performs large-scale mining for drug screening and bioassay datasets. The company has developed multiple virtual screening technologies, such as BEAR (bioactive compound enrichment by assay repositioning) registered in US and Korea, and BACoN registered in Korea patents for drug virtual screening services.
Who invested in Kaipharm Co.
7 investors across 1 round
See all investors in Kaipharm Co.
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
Jan 23, 2020
Amount
$4.3M
Investors
Questions about Kaipharm Co.
Who invested in Kaipharm Co.?
Kaipharm Co. has 7 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Kaipharm Co. raised?
Kaipharm Co. has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Kaipharm Co. last raise money?
Kaipharm Co.'s most recent round on record is a Series A, in Jan 2020.
What does Kaipharm Co. do?
Based in Seoul, South Korea, and founded in 2018 by CEO Wankyu Kim, Kaipharm Co.
Where is Kaipharm Co. headquartered?
Kaipharm Co. is headquartered in Seoul, South Korea.
Which VCs invest in companies like Kaipharm Co.?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back biotechnology companies at Kaipharm Co.'s stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like Kaipharm Co.? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.